:max_bytes(133120)/d1qcnx2r3xkirq.cloudfront.net/pubmed-llm-images/41674622/86d31e66419178e77bc79b9e6dfd8a18_wm.png)
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy.
Summary: Right now, there is no cure for HIV. People usually have to take medicine every day to stay healthy. But scientists are testing a new idea using special infection-fighting proteins called "bNAbs." In a recent study, people with HIV got these bNAbs and then stopped their daily medicine. Amazingly, 3 out of 4 people kept the virus under control for 20 weeks! The bNAbs acted almost like a vaccine, waking up the body's own "T cells" to fight the virus. The stronger a person's T cells were at the start, the longer they could go without the virus coming back. This brings us one step closer to a true cure for HIV.
Tags
HIV Infections
Infections
Enzyme-Linked Immunospot Assay